Plumino Precision Fermentation Europe Gm
About
Company description
Founded in 2025, the company specializes in the research, development and production of amino acid derivatives, with a number of patents on its core technologies, and its products serve customers in the pharmaceutical, nutritional health and scientific research fields in many countries around the world.
Plumino has acquired the pharmaceutical, food and feed-grade, amino acids, and Human Milk Oligosaccharides (HMOs) businesses and related assets from Kyowa Hakko Bio Co., Ltd.
Kyowa Hakko Bio, established on October 1, 2008, traces its origins to the Biochemical Division of Kyowa Hakko Kogyo Co., Ltd. founded in 1949. As a pioneer in amino acid fermentation technology, Kyowa Hakko Bio specialized in producing high-purity, pharmaceutical-grade amino acids through advanced fermentation processes for extensive applications in pharmaceuticals and healthcare.
Leveraging Kyowa Hakko Bio’s 70+ years of technological expertise, Plumino will continue to explore biotechnology frontiers. We are poised to drive innovation and excellence in biotechnology and amino acid research, continually expanding the possibilities within the life science industry
Quick facts
| Sales markets | Africa; Eastern Europe; Western Europe |
|---|---|
| Primary business activity | Manufacturer: Ingredients / Additives |
| Affiliated categories: | Amino acids |L-leucine More |
